Suppose one of the drugs under investigation for COVID-19 effectively reduces its morbidity and mortality. For simplicity let's say that it quickly and completely cures 90% (or X%) of patients but does nothing to the remaining 10%, and we manage to scale up manufacturing enough to be able to treat everyone with the drug. Would the major developed countries then decide to relax the current mitigation/suppression policies and let the pandemic run its course (thereby accepting the morbidity/mortality of the refractory 10%) in order to revive their economies? What do you think the threshold for X would be for the major developed countries to do this?

I feel like there's wet spaghetti code at both ends of this? On one side we have economic impact projections that vary about an order of magnitude and the other we have expected death projections that vary over 1-2 orders of magnitude.

March Coronavirus Open Thread

by Elizabeth 1 min read8th Mar 2020373 comments


This thread was created on 3/8/2020, or approximately one million years ago in virus time. It’s getting pretty bloated now, and a lot of things that were high value at the time have been eclipsed by events, making karma not a very useful sorting tool. So I’m declaring this thread finished, and asking everyone to move over to the April Coronavirus Open Thread.

Interested in what happened in this thread? Here’s the timeless or not-yet-eclipsed highlights:

  • Scott Alexander comes up with Hammer and Dance 6 days before Tomas Pueyo
  • Spiracular on why SARS-Cov-2 is unlikely to be lab-created.
  • Two documents collating estimates of basic epidemiological parameters, in response to this thread
  • Discussion on whether the tuberculosis vaccine provides protection against COVID-19.
  • Suggestive evidence that COVID-19 removes sense of taste and smell.
  • Could copper tape be net harmful?